title: ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.
authors.forename: Jake
authors.initials: J
authors.lastname: Shortt
authors.forename: Danielle H
authors.initials: DH
authors.lastname: Oh
authors.forename: Stephen S
authors.initials: SS
authors.lastname: Opat
mesh_terms: D051722:ADAM Proteins / Q000276:immunology*; D000071120:ADAMTS13 Protein; D001323:Autoantibodies / Q000097:blood*; D001402:B-Lymphocytes / Q000187:drug effects*; D001897:Boronic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008875:Middle Aged; D010950:Plasma Cells / Q000187:drug effects*; D011480:Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy / Q000276:immunology*; D011719:Pyrazines / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D001323:Autoantibodies; D001897:Boronic Acids; D007166:Immunosuppressive Agents; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human